207 related articles for article (PubMed ID: 15137906)
1. Use of the BRET 7TM receptor/beta-arrestin assay in drug discovery and screening.
Heding A
Expert Rev Mol Diagn; 2004 May; 4(3):403-11. PubMed ID: 15137906
[TBL] [Abstract][Full Text] [Related]
2. G protein-independent cell-based assays for drug discovery on seven-transmembrane receptors.
Verkaar F; van Rosmalen JW; Blomenröhr M; van Koppen CJ; Blankesteijn WM; Smits JF; Zaman GJ
Biotechnol Annu Rev; 2008; 14():253-74. PubMed ID: 18606367
[TBL] [Abstract][Full Text] [Related]
3. Distinct conformational changes in beta-arrestin report biased agonism at seven-transmembrane receptors.
Shukla AK; Violin JD; Whalen EJ; Gesty-Palmer D; Shenoy SK; Lefkowitz RJ
Proc Natl Acad Sci U S A; 2008 Jul; 105(29):9988-93. PubMed ID: 18621717
[TBL] [Abstract][Full Text] [Related]
4. Development of a BRET2 screening assay using beta-arrestin 2 mutants.
Vrecl M; Jorgensen R; Pogacnik A; Heding A
J Biomol Screen; 2004 Jun; 9(4):322-33. PubMed ID: 15191649
[TBL] [Abstract][Full Text] [Related]
5. Beta-arrestin-biased ligands at seven-transmembrane receptors.
Violin JD; Lefkowitz RJ
Trends Pharmacol Sci; 2007 Aug; 28(8):416-22. PubMed ID: 17644195
[TBL] [Abstract][Full Text] [Related]
6. beta-Arrestin recruitment assay for the identification of agonists of the sphingosine 1-phosphate receptor EDG1.
van Der Lee MM; Bras M; van Koppen CJ; Zaman GJ
J Biomol Screen; 2008 Dec; 13(10):986-98. PubMed ID: 19036707
[TBL] [Abstract][Full Text] [Related]
7. Bioluminescence Resonance Energy Transfer (BRET) to Detect the Interactions Between Kappa Opioid Receptor and Nonvisual Arrestins.
Bedini A
Methods Mol Biol; 2021; 2201():45-58. PubMed ID: 32975788
[TBL] [Abstract][Full Text] [Related]
8. Bimolecular fluorescence complementation: lighting up seven transmembrane domain receptor signalling networks.
Rose RH; Briddon SJ; Holliday ND
Br J Pharmacol; 2010 Feb; 159(4):738-50. PubMed ID: 20015298
[TBL] [Abstract][Full Text] [Related]
9. Beta-arrestin-based Bret2 screening assay for the "non"-beta-arrestin binding CB1 receptor.
Vrecl M; Nørregaard PK; Almholt DL; Elster L; Pogacnik A; Heding A
J Biomol Screen; 2009 Apr; 14(4):371-80. PubMed ID: 19403920
[TBL] [Abstract][Full Text] [Related]
10. Detection of GPCR/beta-arrestin interactions in live cells using bioluminescence resonance energy transfer technology.
Kocan M; Pfleger KD
Methods Mol Biol; 2009; 552():305-17. PubMed ID: 19513659
[TBL] [Abstract][Full Text] [Related]
11. A homogeneous fluorescent live-cell assay for measuring 7-transmembrane receptor activity and agonist functional selectivity through beta-arrestin recruitment.
Hanson BJ; Wetter J; Bercher MR; Kopp L; Fuerstenau-Sharp M; Vedvik KL; Zielinski T; Doucette C; Whitney PJ; Revankar C
J Biomol Screen; 2009 Aug; 14(7):798-810. PubMed ID: 19531663
[TBL] [Abstract][Full Text] [Related]
12. Biased signaling regulates the pleiotropic effects of the urotensin II receptor to modulate its cellular behaviors.
Brulé C; Perzo N; Joubert JE; Sainsily X; Leduc R; Castel H; Prézeau L
FASEB J; 2014 Dec; 28(12):5148-62. PubMed ID: 25183668
[TBL] [Abstract][Full Text] [Related]
13. Study of GPCR-protein interactions by BRET.
Kocan M; Pfleger KD
Methods Mol Biol; 2011; 746():357-71. PubMed ID: 21607868
[TBL] [Abstract][Full Text] [Related]
14. Monitoring interactions between G-protein-coupled receptors and beta-arrestins.
Pfleger KD; Dalrymple MB; Dromey JR; Eidne KA
Biochem Soc Trans; 2007 Aug; 35(Pt 4):764-6. PubMed ID: 17635143
[TBL] [Abstract][Full Text] [Related]
15. Bioluminescence resonance energy transfer (BRET) to detect the interactions between kappa opioid receptor and non visual arrestins.
Bedini A
Methods Mol Biol; 2015; 1230():115-28. PubMed ID: 25293320
[TBL] [Abstract][Full Text] [Related]
16. Role of receptor-attached phosphates in binding of visual and non-visual arrestins to G protein-coupled receptors.
Gimenez LE; Kook S; Vishnivetskiy SA; Ahmed MR; Gurevich EV; Gurevich VV
J Biol Chem; 2012 Mar; 287(12):9028-40. PubMed ID: 22275358
[TBL] [Abstract][Full Text] [Related]
17. Improved donor/acceptor BRET couples for monitoring beta-arrestin recruitment to G protein-coupled receptors.
Kamal M; Marquez M; Vauthier V; Leloire A; Froguel P; Jockers R; Couturier C
Biotechnol J; 2009 Sep; 4(9):1337-44. PubMed ID: 19557797
[TBL] [Abstract][Full Text] [Related]
18. Monitoring G protein-coupled receptor activation using an adenovirus-based β-arrestin bimolecular fluorescence complementation assay.
Song YB; Park CO; Jeong JY; Huh WK
Anal Biochem; 2014 Mar; 449():32-41. PubMed ID: 24361713
[TBL] [Abstract][Full Text] [Related]
19. Methods to Monitor the Trafficking of β-Arrestin/G Protein-Coupled Receptor Complexes Using Enhanced Bystander BRET.
Cao Y; Namkung Y; Laporte SA
Methods Mol Biol; 2019; 1957():59-68. PubMed ID: 30919346
[TBL] [Abstract][Full Text] [Related]
20. A homogeneous enzyme fragment complementation-based beta-arrestin translocation assay for high-throughput screening of G-protein-coupled receptors.
Zhao X; Jones A; Olson KR; Peng K; Wehrman T; Park A; Mallari R; Nebalasca D; Young SW; Xiao SH
J Biomol Screen; 2008 Sep; 13(8):737-47. PubMed ID: 18660457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
